<http://schema.org/description>
"An FDA approval provides a boost to two companies, while two separate clinical updates send shareholders running for the hills."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2013/05/11/this-week-in-biotech-26.aspx>